HGF
2 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors (NCT03175224) | Apollomics Inc. | 2017-09-27 |
Track HGF automatically
Every clearance here is in the API, with alerts when new ones post.